Mindbody Inc. (NASDAQ:MB) Director Bessemer Venture Partners Vii sold 2,448,346 shares of the company’s stock in a transaction dated Thursday, November 10th. The shares were sold at an average price of $20.00, for a total transaction of $48,966,920.00. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website.

Bessemer Venture Partners Vii also recently made the following trade(s):

  • On Monday, November 7th, Bessemer Venture Partners Vii sold 142,200 shares of Mindbody stock. The shares were sold at an average price of $20.02, for a total transaction of $2,846,844.00.
  • On Friday, August 26th, Bessemer Venture Partners Vii sold 45,000 shares of Mindbody stock. The shares were sold at an average price of $17.20, for a total transaction of $774,000.00.
  • On Monday, August 22nd, Bessemer Venture Partners Vii sold 500,000 shares of Mindbody stock. The shares were sold at an average price of $16.95, for a total transaction of $8,475,000.00.

Mindbody Inc. (NASDAQ:MB) opened at 20.30 on Tuesday. The company has a 50-day moving average of $19.17 and a 200 day moving average of $16.79. Mindbody Inc. has a 52-week low of $9.20 and a 52-week high of $21.05. The firm’s market cap is $822.23 million.

Mindbody (NASDAQ:MB) last issued its quarterly earnings results on Wednesday, October 26th. The company reported ($0.09) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.12) by $0.03. Mindbody had a negative net margin of 22.30% and a negative return on equity of 28.08%. The firm had revenue of $35.30 million for the quarter, compared to analyst estimates of $35.02 million. During the same period in the previous year, the business earned ($0.19) EPS. The company’s revenue was up 35.2% compared to the same quarter last year. On average, equities research analysts anticipate that Mindbody Inc. will post ($0.39) EPS for the current year.

Insider Buying and Selling by Quarter for Mindbody (NASDAQ:MB)

A number of equities research analysts have issued reports on MB shares. Zacks Investment Research upgraded shares of Mindbody from a “hold” rating to a “buy” rating and set a $22.00 price target for the company in a report on Thursday, November 3rd. Roth Capital set a $23.00 price objective on shares of Mindbody and gave the company a “buy” rating in a research report on Thursday, October 20th. Pacific Crest reaffirmed a “buy” rating and set a $22.00 price objective (up previously from $20.00) on shares of Mindbody in a research report on Tuesday, September 13th. Morgan Stanley upped their price objective on shares of Mindbody from $17.00 to $20.00 and gave the company an “equal weight” rating in a research report on Thursday, July 28th. Finally, JMP Securities upped their price objective on shares of Mindbody from $19.00 to $25.00 and gave the company a “market outperform” rating in a research report on Thursday, July 28th. One research analyst has rated the stock with a hold rating and seven have assigned a buy rating to the stock. Mindbody currently has an average rating of “Buy” and a consensus target price of $22.71.

A number of large investors have recently modified their holdings of the stock. Capital World Investors increased its position in shares of Mindbody by 573.1% in the third quarter. Capital World Investors now owns 1,001,276 shares of the company’s stock worth $19,685,000 after buying an additional 852,515 shares during the period. JPMorgan Chase & Co. increased its position in shares of Mindbody by 595,629.9% in the first quarter. JPMorgan Chase & Co. now owns 637,431 shares of the company’s stock worth $8,497,000 after buying an additional 637,324 shares during the period. BlackRock Fund Advisors increased its position in shares of Mindbody by 6,477.5% in the third quarter. BlackRock Fund Advisors now owns 392,347 shares of the company’s stock worth $7,714,000 after buying an additional 386,382 shares during the period. Abdiel Capital Advisors LP increased its stake in shares of Mindbody by 11.9% in the second quarter. Abdiel Capital Advisors LP now owns 2,814,260 shares of the company’s stock valued at $45,422,000 after buying an additional 299,160 shares during the last quarter. Finally, Gilder Gagnon Howe & Co. LLC bought a new stake in shares of Mindbody during the third quarter valued at approximately $5,126,000. Hedge funds and other institutional investors own 59.06% of the company’s stock.

Mindbody Company Profile

MINDBODY, Inc is a provider of cloud-based business management software for the wellness services industry and operates as a consumer marketplace with over 51,000 local business subscribers on its platform in over 130 countries and territories. The Company’s subscribers provide a range of wellness services to approximately 28 million active consumers.

5 Day Chart for NASDAQ:MB

Receive News & Stock Ratings for Mindbody Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mindbody Inc. and related stocks with our FREE daily email newsletter.